Barrington Research Maintains Outperform on Imax, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst James Goss has reiterated an 'Outperform' rating for Imax (NYSE:IMAX) and maintained a price target of $24.
October 31, 2024 | 1:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research analyst James Goss has reiterated an 'Outperform' rating for Imax and maintained a price target of $24, indicating confidence in the company's future performance.
The reaffirmation of the 'Outperform' rating and the maintenance of a $24 price target by Barrington Research suggests a positive outlook for Imax. This could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100